5FQ-20472-90543
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 926 / CA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
-
2021-03-15
Survey response — days 1–6 daily, dose 1MedDRA: Epistaxis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Bloody noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-20
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-09-08
- 2021-09-29
- 2022-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-15 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Bloody nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Epistaxis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release